<unk> (ophthalmic) is an anti-inflammatory agent that is FDA approved for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, corneal injury from chemical, thermal burns, or penetration of foreign bodies, and steroid responsive inflammatory conditions of the external auditory meatus, such as allergic otitis externa, selected purulent and nonpurulent infective otitis externa.   Common adverse reactions include glaucoma with optic nerve damage, visual acuity and visual field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, and perforation of the globe.
Dexamethasone 
Hydrocortisone 
Fluocortolone
Cortisone
Aminoglutethimide
Mifepristone
Betamethasone valerate 
Human menopausal gonadotropin